--

0 (Fibrinolytic Agents), 21829-25-4 (Nifedipine), 55-63-0 (Nitroglycerin), Adult, Clinical Trials, Coronary Vessels, EC 3.4.- (Streptokinase), EC 3.4.21.73 (Urinary Plasminogen Activator), Fibrinolysis, Fibrinolytic Agents/administration & dosage/*therapeutic use, Heart Catheterization, Human, Male, Middle Aged, Myocardial Infarction/*drug therapy, Nifedipine/therapeutic use, Nitroglycerin/therapeutic use, Pilot Projects, Random Allocation, Risk, Streptokinase/administration & dosage/therapeutic use, Urinary Plasminogen Activator/administration & dosage/therapeutic use
hdl.handle.net/1765/4063
European Heart Journal
Erasmus MC: University Medical Center Rotterdam

Serruys, P.W.J.C, van den Brand, M.J.B.M, Hooghoudt, T.E.H, Simoons, M.L, Fioretti, P.M, Ruiter, J.P.N, … Hugenholtz, P.G. (1982). Coronary recanalization in acute myocardial infarction: immediate results and potential risks. European Heart Journal, 3, 404–415. Retrieved from http://hdl.handle.net/1765/4063